Global Recombinant Human EGF Market Is Estimated To Witness High Growth Owing To Increasing Investments in Research and Development and Rising Prevalence of Chronic Diseases
  The Recombinant Human EGF Market is estimated to be valued at US$ 9.3 billion in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period of 2023 to 2028, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Recombinant Human EGF Market refers to the market for recombinant human epidermal growth factors (EGF), which are used in various...
0 Комментарии 0 Поделились 1147 Просмотры 0 предпросмотр
Спонсоры